Purchase Order 75F40119P10294
Award Date 7/29/19
Potential Completion Date 7/30/20
Potential Value $936K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Nexight Group LLC, a regulatory consulting firm, for the development of standards for regenerative medicine therapies. The $2,921,928.00 contract supports the modification of an existing contract to add a workshop on reference materials and standards, publish fact sheets, and summarize relevant standards. Nexight has already established an organization of stakeholders and...
- The Department of Health and Human Services' Food and Drug Administration awarded a $157,134 firm fixed price delivery order contract to Regan Technologies Corporation. This order is placed against Solutions for Enterprise-Wide Procurement V, a government-wide acquisition contract vehicle, to provide CLC BIO software licenses. The place of performance is Silver Spring, Maryland. The one-year contract begins on September 27, 2023 and concludes on September 29, 2024. As the FDA works to protect...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...
- The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
- This is a federal contract award from the Food and Drug Administration (FDA) to the Health and Environmental Sciences Institute (HESI), a non-profit organization. The contract, worth $267,658.00, is for a project titled "VALIDATING HUMAN STEM CELL CARDIOMYOCYTE TECHNOLOGY FOR BETTER PREDICTIVE ASSESSMENT OF DRUG-INDUCED CARDIAC TOXICITY." The contract is a definitive contract with a firm fixed price. This contract appears to be supporting the FDA's efforts to evaluate the reliability...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $110,000 delivery order contract to Illumina, Inc. for Illumina Reagent Chemistry Kits. The firm fixed price contract runs from April 5, 2023 through September 25, 2023 and will be performed in Silver Spring, Maryland. The HHS FDA utilizes next generation sequencing technologies and associated reagents in its regulatory and research activities. No subcontractors or set aside designations were identified....
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a purchase order contract to Government Solutions Group, LLC, a SBA certified 8(a) program participant, minority-owned, and Native American-owned small business. The contract, awarded on March 3, 2023, provides CDRH Strategic Priorities Support services to be performed in Silver Spring, MD with a potential value of $216,743.95 and a completion date of September 30, 2023. The contract is a labor hours...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $1,009,892 to The Medical Device Innovation Consortium (MDIC) on January 28, 2026, to provide support for medical device innovation and regulatory science initiatives. This firm fixed-price delivery order, which is not set aside for small business, will be performed in Rosslyn, Virginia and is scheduled for completion by February 22, 2028. MDIC is a non-profit organization specializing in advancing regulatory science for...
- The Food and Drug Administration awarded a $1,085,530 definitive contract to Genentech Inc. on September 11, 2025, for advanced research and development in regulatory science addressing hybrid randomized controlled trials in longitudinal settings, with emphasis on causal methodologies for managing diverse missing data patterns. The contract was issued under a Fiscal Year 2025 Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which solicited proposals across...